KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesAmortizatization of IntangiblesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in ReceivablesDeferred TaxesDepreciation & Amortization (CF)Free Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesOther financing activitiesShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Oscar Health (OSCR) Change in Acquisitions & Divestments (2020 - 2025)

Oscar Health (OSCR) has disclosed Change in Acquisitions & Divestments for 6 consecutive years, with -$343.9 million as the latest value for Q4 2025.

  • For the quarter ending Q4 2025, Change in Acquisitions & Divestments changed N/A year-over-year to -$343.9 million, compared with a TTM value of $134.2 million through Dec 2025, changed N/A, and an annual FY2025 reading of $134.2 million, changed N/A over the prior year.
  • Change in Acquisitions & Divestments was -$343.9 million for Q4 2025 at Oscar Health, down from $210.8 million in the prior quarter.
  • Across five years, Change in Acquisitions & Divestments topped out at $1.4 billion in Q4 2023 and bottomed at -$684.8 million in Q3 2023.
  • Average Change in Acquisitions & Divestments over 5 years is $203.8 million, with a median of $169.4 million recorded in 2022.
  • Peak annual rise in Change in Acquisitions & Divestments hit 840.75% in 2023, while the deepest fall reached 685.05% in 2023.
  • Year by year, Change in Acquisitions & Divestments stood at $202.0 million in 2021, then surged by 35.13% to $273.0 million in 2022, then surged by 406.75% to $1.4 billion in 2023, then plummeted by 52.08% to $663.0 million in 2024, then crashed by 151.88% to -$343.9 million in 2025.
  • Business Quant data shows Change in Acquisitions & Divestments for OSCR at -$343.9 million in Q4 2025, $210.8 million in Q3 2025, and $251.7 million in Q2 2025.